Honeywell Gains From Strength in Aerospace Unit: Can the Momentum Sustain?

Honeywell's Aerospace Technologies organic revenue rose 21% YoY in Q4 2025 and now represents over 46% of the business; commercial aviation aftermarket organic sales increased 13% YoY in Q4 (prior quarters: +15%, +7%, +19%). Management expects Aerospace Technologies organic sales to be up in the high-single-digit range in 2026, driven by commercial aviation OEM/aftermarket strength and defense & space demand, while peers Howmet saw defense aerospace revenue +20% in Q4 and RTX reported Q4 sales +12.1%. Shares have gained 5.7% over the past year, HON trades at a forward P/E of 21.40x vs industry 15.42x, and Zacks consensus 2026 EPS estimate has inched up 0.6% over 60 days (Zacks Rank #3).

Analysis

Aerospace demand normalization and supply‑chain repair are creating asymmetric winners: firms exposed to multi‑year defense spares streams (F‑35 and legacy fighter sustainment), specialty materials suppliers and precision MRO networks will see steady, less cyclical cash flow than pure commercial OEM suppliers. Improved OEM cadence reduces emergency AOG orders and spot‑market price volatility for parts, which should compress aftermarket spot premia and benefit vertically integrated OEMs that capture both new build and aftermarket margins.

Key catalysts and timelines are distinct: near‑term (days–weeks) moves will be driven by quarterly numbers and any updated 2026 cadence commentary; medium term (3–12 months) by F‑35 lot award timing, airline utilization trends and inventory destocking/re‑stocking dynamics; and multi‑year returns depend on defense budget appropriations and the pace of fleet replacement/green retrofits. Tail risks that can reverse the trend include a macro pullback in air travel demand, step‑down in defense procurement funding, or a renewed materials inflation spike (titanium/nickel) that compresses margins for midstream suppliers.

Consensus currently underprices two offsets: (1) a likely gradual compression of aftermarket margin pools as OEM production and supplier on‑time delivery normalize, and (2) valuation risk for diversified names that trade at a premium despite cyclic exposure. That makes a directional long on pure defense spare plays and a hedged/relative‑value stance within diversified aerospace names the higher‑probability way to capture the structural tailwinds while protecting against multiple reversion.

Key Decisions for Investors

• Buy HWM equity (12‑month horizon). Rationale: direct exposure to defense spares (F‑35/legacy fighters) with multi‑year visibility. Target +30% upside in 12 months if Lot buys/leads persist; downside -25% on program delays or budget cuts. Position size: 2‑3% of equity risk budget.
• Initiate a 6–12 month pair: long HWM / short HON (equal dollar notional). Rationale: capture defense spare outperformance vs premium‑valued diversified aerospace exposure and hedge cyclical commercial risk. Target 20% relative spread return; max drawdown ~12–15% if HON continues to rerate higher. Use monthly rebalancing and a stop if spread narrows by 10%.
• Buy a short‑dated protective put spread on HON (3–4 months). Rationale: low‑cost downside protection against multiple compression around upcoming guidance/earnings. Cost ~1–3% of notional, payoff begins if HON falls >10% and caps at ~15–20% — efficient hedge for 1–2% portfolio exposure.
• If conviction rises on defense appropriation clarity, add selective long exposure to precision MRO/specialty metal suppliers (via HWM or peers) rather than broad aerospace ETFs — preference for single‑name exposure with visible backlog and >12 month contract ladders. Target 12–24 month hold, reward 25–40%, risk company‑specific execution (~30%).